PerkinElmer, Inc.  

(Public, NYSE:PKI)   Watch this stock  
Find more results for Custom Living, Inc
Nov 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 37.23 - 48.26
Open     -
Vol / Avg. 0.00/1.03M
Mkt cap 5.16B
P/E 26.18
Div/yield 0.07/0.61
EPS 1.74
Shares 112.96M
Beta 0.92
Inst. own 94%
Jan 28, 2015
Q4 2014 PerkinElmer Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 2, 2014
PerkinElmer Inc at Piper Jaffray Healthcare Conference - 11:30AM EST - Add to calendar
Nov 19, 2014
PerkinElmer Inc at Jefferies Global Healthcare Conference - London
Oct 30, 2014
Q3 2014 PerkinElmer Inc Earnings Call - Webcast
Oct 30, 2014
Q3 2014 PerkinElmer Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 7.91% 7.75%
Operating margin 10.84% 10.04%
EBITD margin - 17.62%
Return on average assets 4.40% 4.28%
Return on average equity 8.36% 8.54%
Employees 7,600 -
CDP Score - 62 D


United States - Map
+1-781-6635776 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through the Company�s advanced technologies, solutions, and services, it addresses issues related to health and safety of people and their environment. It operates in two segments: Human Health and Environmental Health. The Company�s Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier and accelerate the discovery and development of critical new therapies. The Company�s Environmental Health segment provides technologies and applications to facilitate the creation of safer food and consumer products, secure surroundings and energy resources.

Officers and directors

Robert F. Friel Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank Anders Wilson CPA Chief Financial Officer, Senior Vice President
Age: 55
Bio & Compensation  - Reuters
Daniel R. Marshak Ph.D. Chief Scientific Officer, Senior Vice President, President - Emerging Diagnostics
Age: 56
Bio & Compensation  - Reuters
Joel S. Goldberg Senior Vice President, General Counsel, Secretary
Age: 45
Bio & Compensation  - Reuters
John R. Letcher Senior Vice President - Human Resources
Age: 52
Bio & Compensation  - Reuters
James L. Corbett Senior Vice President, President - Diagnostics
Age: 51
Bio & Compensation  - Reuters
Jon DiVincenzo Senior Vice President, President - Environmental Health
Bio & Compensation  - Reuters
Maurice H. Tenney III Senior Vice President, President - Global Operations and Customer Logistics
Age: 50
Bio & Compensation  - Reuters
Andrew Okun Chief Accounting Officer, Vice President
Age: 44
Bio & Compensation  - Reuters
Nicholas A. Lopardo Lead Independent Director
Age: 67
Bio & Compensation  - Reuters